BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 18690884)

  • 1. Radiopharmaceuticals in neurological and psychiatric disorders.
    Valotassiou V; Wozniak G; Sifakis N; Demakopoulos N; Georgoulias P
    Curr Clin Pharmacol; 2008 May; 3(2):99-107. PubMed ID: 18690884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent and future evolutions in NeuroSPECT with particular emphasis on the synergistic use and fusion of imaging modalities.
    d'Asseler YM; Koole M; Lemahieu I; Achten E; Boon P; De Deyn PP; Dierckx RA
    Acta Neurol Belg; 1997 Sep; 97(3):154-62. PubMed ID: 9345586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of cerebral SPECT.
    McArthur C; Jampana R; Patterson J; Hadley D
    Clin Radiol; 2011 Jul; 66(7):651-61. PubMed ID: 21371697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET and SPECT imaging of the NMDA receptor system: an overview of radiotracer development.
    Sobrio F; Gilbert G; Perrio C; Barré L; Debruyne D
    Mini Rev Med Chem; 2010 Aug; 10(9):870-86. PubMed ID: 20504276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands.
    Kegeles LS; Mann JJ
    Neuropsychopharmacology; 1997 Nov; 17(5):293-307. PubMed ID: 9348545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronuclear assessment of patients with epilepsy.
    Goffin K; Dedeurwaerdere S; Van Laere K; Van Paesschen W
    Semin Nucl Med; 2008 Jul; 38(4):227-39. PubMed ID: 18514079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropharmacological studies with SPECT in neuropsychiatric disorders.
    Heinz A; Jones DW; Raedler T; Coppola R; Knable MB; Weinberger DR
    Nucl Med Biol; 2000 Oct; 27(7):677-82. PubMed ID: 11091111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiopharmaceuticals for brain imaging.
    Saha GB; MacIntyre WJ; Go RT
    Semin Nucl Med; 1994 Oct; 24(4):324-49. PubMed ID: 7817203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers in Randomized Clinical Trials: Positron Emission Tomography and Nuclear Medicine Techniques.
    Singhal T; Stern E
    Front Neurol Neurosci; 2016; 39():109-16. PubMed ID: 27463807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography in the investigation of neuropsychiatric disorders: update and comparison with magnetic resonance imaging and computerized tomography.
    Wegener WA; Alavi A
    Int J Rad Appl Instrum B; 1991; 18(6):569-82. PubMed ID: 1743981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of central nervous system disorders with single photon emission computed tomography and positron emission tomography: evolution over the past 2 decades.
    Alavi A; Hirsch LJ
    Semin Nucl Med; 1991 Jan; 21(1):58-81. PubMed ID: 1996428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of brain imaging instrumentation.
    Abraham T; Feng J
    Semin Nucl Med; 2011 May; 41(3):202-19. PubMed ID: 21440696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders.
    Virdee K; Cumming P; Caprioli D; Jupp B; Rominger A; Aigbirhio FI; Fryer TD; Riss PJ; Dalley JW
    Neurosci Biobehav Rev; 2012 Apr; 36(4):1188-216. PubMed ID: 22342372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nuclear medicine imaging: new radiotracers and future techniques].
    Semah F
    Neurochirurgie; 2008 May; 54(3):231-5. PubMed ID: 18440564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single photon emission computed tomography in psychiatry: current perspectives.
    Vasile RG
    Harv Rev Psychiatry; 1996; 4(1):27-38. PubMed ID: 9384969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPECT imaging in psychiatry: introduction and overview.
    Weinberger DR
    J Clin Psychiatry; 1993 Nov; 54 Suppl():3-5. PubMed ID: 8270596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional brain imaging in the evaluation of psychiatric illness.
    Van Heertum RL; O'Connell RA
    Semin Nucl Med; 1991 Jan; 21(1):24-39. PubMed ID: 1996426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET and SPECT Imaging of the Brain: History, Technical Considerations, Applications, and Radiotracers.
    Davis KM; Ryan JL; Aaron VD; Sims JB
    Semin Ultrasound CT MR; 2020 Dec; 41(6):521-529. PubMed ID: 33308491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of regional cerebral function with FDG-PET imaging in neuropsychiatric disorders.
    Newberg A; Alavi A; Reivich M
    Semin Nucl Med; 2002 Jan; 32(1):13-34. PubMed ID: 11839066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical brain radionuclide imaging studies.
    Messa C; Fazio F; Costa DC; Ell PJ
    Semin Nucl Med; 1995 Apr; 25(2):111-43. PubMed ID: 7597417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.